Alzheimer's and Parkinson's disease therapies in the clinic
Abstract Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent neurodegenerative diseases, affecting millions and costing billions each year in the United States alone. Despite tremendous progress in developing therapeutics that manage the symptoms of these two disea...
Saved in:
Main Authors: | Puja Chopade, Neha Chopade, Zongmin Zhao, Samir Mitragotri, Rick Liao, Vineeth Chandran Suja |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Bioengineering & Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/btm2.10367 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association analyses of nutritional markers with Parkinson’s disease and Alzheimer’s disease
by: Dong-Juan Xu, et al.
Published: (2024-11-01) -
Hydrogels in the clinic: An update
by: John R. Clegg, et al.
Published: (2024-11-01) -
Application of optical coherence tomography in neurodegenerative diseases: a focus on Parkinson’s, Alzheimer’s, and Schizophrenia in Bulgarian patients
by: Alina Y. Levi, et al.
Published: (2024-12-01) -
Physical exercise-mediated neuroprotective mechanisms in Parkinson's disease, Alzheimer's disease, and epilepsy
by: R.A. Pinho, et al.
Published: (2024-11-01) -
Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
by: Chengyong Liu, et al.
Published: (2025-01-01)